Enterome

Enterome is pioneering the development of novel microbiome based drugs to treat cancer and GI track related disorders.

Enterome's treatments are based on its proprietary Metasecretome technology, which is further divided into its OncoMimics and EndoMimics platforms. The company enables a full genomic and functional analysis of the gut microbiome and utilizes naturally occurring proteins and hormones produced by the gut bacteria for the treatment of its patients.